Trials / Completed
CompletedNCT00262678
Efficacy and Safety of Sublingual Fentanyl Tablets in Treatment of Breakthrough Pain in Cancer Patients.
A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of EN3267 for the Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Kyowa Kirin Co., Ltd. · Industry
- Sex
- All
- Age
- 17 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the effectiveness and safety of sublingual fentanyl tablets in relieving breakthrough pain in cancer patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | EN3267 |
Timeline
- Start date
- 2005-12-01
- Primary completion
- 2008-12-01
- Completion
- 2009-01-01
- First posted
- 2005-12-07
- Last updated
- 2009-06-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00262678. Inclusion in this directory is not an endorsement.